Triphenylphosphine → Tert-butyl 4-(6-bromo-2-chloro-quinazolin-8-yloxy)-piperidine-1-carboxylate
Reaction equation
C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.CC(OC(/N=N/C(OC(C)(C)C)=O)=O)(C)C.[OH:36][CH:37]1[CH2:42][CH2:41][N:40]([C:43]([O:45][C:46]([CH3:49])([CH3:48])[CH3:47])=[O:44])[CH2:39][CH2:38]1.[Br:50][C:51]1[CH:52]=[C:53]2[C:58](=[C:59](O)[CH:60]=1)[N:57]=[C:56]([Cl:62])[N:55]=[CH:54]2>C1COCC1.CO>[Br:50][C:51]1[CH:52]=[C:53]2[C:58](=[C:59]([O:36][CH:37]3[CH2:38][CH2:39][N:40]([C:43]([O:45][C:46]([CH3:49])([CH3:48])[CH3:47])=[O:44])[CH2:41][CH2:42]3)[CH:60]=1)[N:57]=[C:56]([Cl:62])[N:55]=[CH:54]2Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 20 °C
Procedure
Triphenylphosphine (577 mg, 2.20 mmol), di-tert-butylazodicarboxylate (506 mg, 2.20 mmol) and tert-butyl 4-hydroxy-piperidine-1-carboxylate (1.32 g, 6.62 mmol) are taken up in 6 mL THF, stirred for 15 min at 20° C. and then combined with 6-bromo-2-chloro-quinazolin-8-ol (1.16 g, 4.45 mmol). After stirring for 24 h at 20° C. the mixture is diluted with MeOH, the solvent is eliminated in vacuo, the crude product is purified by RP-chromatography (method prep. HPLC1; 20% acetonitrile to 90% in 6 min) and tert-butyl 4-(6-bromo-2-chloro-quinazolin-8-yloxy)-piperidine-1-carboxylate (HPLC-MS: tRet.=1.99 min; method FECB5) is obtained.
Workup
- stirringAfter stirring for 24 h at 20° C. the mixture
- customthe crude product is purified by RP-chromatography (method prep. HPLC1; 20% acetonitrile to 90% in 6 min)
Sources & evidence
- ORD record
- ord-6b44ee9e45d842148e17987839f40685
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08637549B2
Reaction notes
Loading…